Alberta Children's Hospital is the largest public hospital for sick children in the prairie provinces, and is located in Calgary, Alberta, Canada. It is operated by Alberta Health Services – Calgary Health Region.

During the past decade, University of Calgary, Alberta Children's Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Calgary, Alberta Children's Hospital" #1 sponsor was "University of British Columbia" with 4 trials, followed by "Pfizer" with 2 trials sponsored, "University of Calgary" with 2 trials sponsored, "Bayer" with 1 trials sponsored and "Duke University" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Calgary, Alberta Children's Hospital" #1 collaborator was "The Hospital for Sick Children" with 4 trials as a collaborator, "Alberta Children's Hospital" with 3 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Childhood Arthritis and Rheumatology Research Alliance" with 2 trials as a collaborator and "Children's Hospital of Eastern Ontario" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "University of Calgary, Alberta Children's Hospital" are "Juvenile Idiopathic Arthritis" (2 trials), "Arthritis Juvenile Idiopathic" (1 trials), "Arthritis, Juvenile Idiopathic" (1 trials), "Autoimmune Rheumatologic Disease" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "University of Calgary, Alberta Children's Hospital" in a lesser frequency.

Most popular intervention types in "University of Calgary, Alberta Children's Hospital" are "Drug" (7 trials), "Biological" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Avaxim Pediatric®" (1 trials), "Avaxim ® (adult)" (1 trials), "Blood sampling" (1 trials) and "CP-690,550 (tofacitinib)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Calgary, Alberta Children's Hospital" are 16 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Calgary, Alberta Children's Hospital". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in University of Calgary, Alberta Children's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Calgary, Alberta Children's Hospital, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".